Value of Gating of Technetium-99m Sestamibi Single-Photon Emission Computed Tomographic Imaging  by Smanio, Paola E.P et al.
Value of Gating of Technetium-99m Sestamibi Single-Photon Emission
Computed Tomographic Imaging
PAOLA E. P. SMANIO, MD,* DENNY D. WATSON, PHD, DANA L. SEGALLA,
ELLEN L. VINSON, WILLIAM H. SMITH, MS, GEORGE A. BELLER, MD, FACC
Charlottesville, Virginia
Objectives. The purpose of this study was to determine how
frequently and for what reasons the addition of electrocardio-
graphically gated technetium-99m (Tc-99m) sestamibi single-
photon emission computed tomographic (SPECT) images add
value to nongated SPECT perfusion images.
Background. Electrocardiographic gating of Tc-99m sestamibi
SPECT images permits assessment of regional and global left
ventricular function and may assist in differentiating attenuation
artifacts from myocardial scar.
Methods. A total of 285 consecutive patients (143 women and
142 men; mean age 57.6 6 11.5 years) underwent gated SPECT
Tc-99m sestamibi imaging (212 with exercise, 63 with dipyri-
damole and 10 with dobutamine). The conventional stress and
rest tomograms were interpreted first by means of a 14-segment
scoring system, and then the studies were reinterpreted while the
gated images were viewed.
Results. In the total group of 285 patients, the number of
“borderline” interpretations was reduced from 89 to 29. In the 137
patients with a <210% pretest likelihood of coronary artery
disease, the addition of gated images added significantly to the
percentage of interpretations that were designated “normal” (74%
[101 of 137] vs. 93% [127 of 137], p < 0.0001), due to a reduction
in borderline normal and borderline abnormal readings. In 49
patients with a previous infarction or recent angiography with
>270% stenosis, or both, the addition of gated images changed the
percentage of “abnormal” scan interpretations from 78% (38 of
49) to 92% (45 of 49). This result was not significant (p 5 0.09,
two-tailed), but the trend was toward a greater number of un-
equivocal abnormal interpretations in this subgroup.
Conclusions. The addition of electrocardiographically gated
Tc-99m sestamibi SPECT images to the reading of stress and rest
perfusion images alone resulted in shifting the final scan inter-
pretations to a more normal designation in patients with a low
pretest likelihood of coronary artery disease, and to more abnor-
mal defects consistent with coronary artery disease in patients
with known coronary artery disease. The number of “borderline
normal” and “borderline abnormal” interpretations are signifi-
cantly reduced when gated SPECT images are interpreted simul-
taneously with stress and rest perfusion images.
(J Am Coll Cardiol 1997;30:1687–92)
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The addition of electrocardiographic (ECG) gating to
technetium-99m (Tc-99m) sestamibi single-photon emission
computed tomography (SPECT) perfusion imaging can pro-
vide additional and potentially useful information (1–17). This
complementary information can be used to help evaluate the
severity of transient regional ischemia and the extent of
myocardial viability. Assessment of global function should be
useful for determining prognosis and in differentiating isch-
emic from nonischemic cardiomyopathy.
Gated SPECT images can also assist in evaluating the
significance of questionable perfusion defects (12). Attenua-
tion artifacts are ubiquitous and problematic for Tc-99m as
well as for thallium-201, particularly when persistent defects
raise the question of myocardial scar versus artifact. The
presence of corresponding normal or abnormal wall motion
might resolve the question.
The purpose of this study was to determine how frequently
and for what reasons the addition of gated images provided
added value to nongated Tc-99m sestamibi SPECT myocardial
perfusion images.
Methods
Patient selection. Two hundred eighty-five consecutive pa-
tients who underwent gated Tc-99m sestamibi SPECT perfu-
sion imaging were studied. Of these, 212 underwent exercise
stress, 63 underwent dipyridamole stress and the remaining 10
underwent dobutamine stress imaging. There were 143 women
and 142 men with a mean age of 57.6 6 11.5 years (range 32 to
87). Nine patients had chest pain with normal coronary
angiograms; 97 had a #5% likelihood of coronary artery
disease (18) and did not undergo coronary angiography; 31 had
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a .5% and #10% likelihood of coronary artery disease and
did not undergo coronary angiography; 60 had a .10%
likelihood of coronary artery disease without clinical evidence
of disease and did not undergo coronary angiography; 37 had
documented coronary artery disease with $50% stenosis on
coronary angiography and no previous infarction; 34 had
previous coronary artery bypass graft surgery or percutaneous
transluminal coronary angioplasty; and the remaining 17 had a
documented previous myocardial infarction.
Procedure. The scintigraphic methods have been described
in detail by Smith et al. (19) and Calnon et al. (20). Briefly,
gated images were acquired on a Picker Prism 3000 triple-
headed gamma camera using a low energy, high resolution,
parallel-hole collimator. Image resolution was 64 3 64 pixels.
Sixty projection images were acquired using the step-and-shoot
method, with 20 stops of 50 to 60 s each. An ECG R wave
detector provided a gate to acquire 8 frames/cardiac cycle.
Three sets of SPECT slices representing summed, end-
diastolic and end-systolic images were formed for computer
display and also on film. The summed image set was normal-
ized conventionally for comparison of stress and rest images.
The gated images were all normalized to the region of highest
activity on the end-systolic image set. The result of this (19,20)
is that the partial volume effect causes the image intensity to
change in response to changes in myocardial wall thickness
when comparing end-systolic and end-diastolic frames. With
this type of normalization, changes in regional wall thickness
can be appreciated by noting increased image intensity in the
end-systolic image compared with the same segment of the
end-diastolic image. This technique has been validated by
Calnon et al. (20).
Scintigraphic interpretation. All Tc-99m sestamibi SPECT
studies were read in blinded manner by two observers (G.A.B.,
D.D.W.) to derive a consensus interpretation. Readers were
given high quality, multiple planar projection images from
which to judge attenuation artifacts. Gender could usually be
inferred by the presence or absence of breast attenuation
shadow. The readers were given no other information from
which to determine the pretest probability of coronary artery
disease. The conventional stress and rest perfusion tomo-
graphic images were interpreted first. After scoring of the
perfusion images was completed, the gated end-systolic and
end-diastolic images were interpreted and the segmental scor-
ing was repeated to derive a final reading.
The myocardium was divided into 14 segments for analysis
of both regional perfusion and function. The segments scored
included the distal and proximal short-axis and the vertical
long-axis tomographic views. The 14 segments on the stress
and rest perfusion images were individually scored as either
normal (which included easily recognized artifacts), borderline
normal, borderline abnormal, abnormal with a moderate de-
fect and abnormal with a severe defect. When compared with
the rest tomograms, defects were further classified as partially
or totally reversible or fixed. Categories for scoring segments
on the gated tomograms were normal, hypokinesia, akinesia,
dyskinesia and nonvisible. The “nonvisible” classification was
used if a perfusion defect in the region was so severe that the
residual tracer activity in that region was judged to be insuffi-
cient for adequate evaluation of wall motion. The same final
overall interpretation procedure was repeated after the gated
tomographic images were viewed. Then, the gated and non-
gated interpretations were compared to identify where the
assessment of the gated tomogram altered the final interpre-
tation of the study. For example, a segment could be scored as
“borderline normal” after reviewing only the stress and rest
perfusion tomogram, and as “normal” after viewing the gated
tomographic images with the perfusion images.
Statistical methods. The Fisher exact test was used to test
for the significance of differences in the number of successful
test outcomes, using perfusion imaging alone and with the
addition of function imaging. A successful test outcome was
defined as being the expected result (i.e., a normal test for
patients in the normal control group and an abnormal test for
patients in the group with known coronary artery disease).
Results
The results of 106 patients with a #5% pretest likelihood of
coronary artery disease are shown in Figure 1A. The addition
of gated SPECT resulted in an increase in normal interpreta-
tions from 80 to 99 and a reduction in borderline abnormal
interpretations from 6 to 2. Patients with a #10% pretest
likelihood were also analyzed and considered as “normal.”
This was done because the classification of #5% excludes most
men in a referred group. Extending the classification to #10%
produces a more representative control group, without unrea-
sonable contamination with patients having significant coro-
nary artery disease. Of the larger group, there was only one
patient with a perfusion defect that appeared typical of coro-
nary artery disease. Including this as a “false positive” result
had no significant effect on the statistical outcome.
The results from 137 patients with a #10% pretest likeli-
hood of coronary artery disease are shown in Figure 1B. The
addition of gated SPECT resulted in an increase in normal
interpretations from 101 to 127 and reductions in borderline
normal interpretations from 26 to 7 and borderline abnormal
interpretations from 10 to 2. The number of abnormal inter-
pretations only increased from 0 to 1 in this low likelihood
group.
There were 49 patients with coronary artery stenosis $70%
on angiography or a documented previous myocardial infarc-
tion, or both (Fig. 2). From perfusion studies alone, 38 of these
were interpreted as abnormal, 9 as borderline and 1 as
Abbreviations and Acronyms
ECG 5 electrocardiographic
SPECT 5 single-photon emission computed tomography
(tomographic)
Tc-99m 5 technetium-99m
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definitely normal. When gating was added, the number of
borderline interpretations was reduced from 9 to 3. There was
one additional false negative result. Thus, five of the six
reclassifications in this subgroup were correct, and one border-
line normal interpretation by perfusion imaging was reclassi-
fied incorrectly to normal with the addition of gated images.
When all subsets are considered together (Fig. 3), 89
patients (31%) had borderline normal or borderline abnormal
interpretations based on perfusion images alone. When the
gated tomograms and stress and rest perfusion images were
interpreted together, the number of these uncertain designa-
tions fell from 89 (32%) to 29 (10%) of the total group. This
shift was not associated with an increase in the number of
abnormal interpretations, consistent with coronary artery dis-
ease in patients with a ,10% pretest likelihood of coronary
artery disease, but it was associated with a greater number of
such abnormal interpretations in patients with documented
coronary artery disease. These shifts resulted in enhanced
specificity of Tc-99m sestamibi for the detection of coronary
artery disease, because more final normal readings ensued
from interpretation of gated tomograms with perfusion images
in patients with a #10% pretest likelihood of coronary artery
disease and more abnormal final readings in patients with
known coronary artery disease.
Figure 4 is a pie chart that summarizes the fraction of
studies with unchanged overall readings and the reasons found
for changing or adding to the interpretation of the perfusion
images after reviewing the gated images. Gated images were
judged to add significant information to about half (45%) of all
the studies. Added value was indicated only if reviewing the
gated images revealed additional information. For example,
observing a wall motion defect in the segment of a large, fixed
perfusion defect was not listed as adding significant informa-
tion. The 22 segments in the “revealed wall motion abnormal-
ity” category were segments where the observation of a wall
motion defect changed our interpretation of a (questionable)
perfusion defect. The category “aided viability assessment”
means, for example, that the finding of preserved wall motion
in a region with a severe perfusion defect leads to the
Figure 2. Number of various test results in 49 patients with known
angiographic coronary artery disease (CAD) or a previous myocardial
infarction (MI) after interpretation of stress and rest Tc-99m sestamibi
SPECT images alone (solid bars) and after repeat interpretation of
perfusion images together with the end-diastolic and end-systolic gated
images (hatched bars). See text for definitions of test results.
Figure 1. Number of various test results in 106 patients with a #5%
(A) and 137 with a #10% (B) pretest likelihood of coronary artery
disease (CAD) after interpretation of stress and rest Tc-99m sestamibi
SPECT images alone (solid bars) and after repeat interpretation of
perfusion images together with the end-diastolic and end-systolic gated
images (hatched bars). See text for definitions of test results.
Figure 3. Changes in test interpretations after interpretation of per-
fusion and function images (hatched bars) compared with stress and
rest perfusion images alone (solid bars) for all 285 patients in the study
referred for evaluation for coronary artery disease (CAD). See text for
definitions of test results.
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implication that there was more residual myocardial viability
than would have been judged solely from the perfusion images.
Another example would be the absence of systolic thickening
in a myocardial segment that had significant (.50%) tracer
uptake. This would lead to a consideration of hibernating or
stunned myocardium. Similarly, the indication of “myopathy”
means that there were only three patients who could be
identified only by reduced function but not identified by the
typical pattern of dilated myopathy when reading the perfusion
images.
Data analysis. The addition of segmental wall motion to
perfusion images adds information not contained in the per-
fusion images alone. The question regarding the additional
information is not whether it is “statistically significant” but
whether it is clinically useful. The wall motion information is
also used to assist in deciding if the perfusion images are
normal or abnormal, which can be tested to see whether the
addition of wall motion information increases the accuracy of
this classification of the perfusion images.
If one considers the 106 patients with a #5% likelihood of
coronary artery disease and uses “normal” as the only success-
ful test outcome, then the addition of gated images adds
significantly (75% vs. 93%, p 5 0.0005). If one considers the
more representative group of 137 patients with a #10% pretest
likelihood of coronary artery disease to be “normal” and uses
“normal” as the only successful test outcome, then the addition
of gated images adds significantly (74% vs. 93%, p , 0.0001 by
the Fisher exact test). For the low-likelihood group of patients,
if one includes either “normal” or “borderline normal” as a
successful outcome, then the differences are not significant.
Specifically, for the #5% group we have 94% vs. 98%, p 5
0.28, and for the #10% group we have 93% vs. 98%, p 5 0.08.
In either case, the addition of gating leads more frequently to
altering the previous interpretation correctly than to altering it
incorrectly, as judged from these subgroups in which “normal”
could be expected as the correct interpretation.
There were 49 patients in this study with coronary artery
stenoses $70% on angiography or with a documented previous
myocardial infarction. This is the subgroup for which we can
most confidently certify “abnormal” as the correct interpreta-
tion of the perfusion images. The interpretations with and
without the addition of gating are shown for this subgroup in
Figure 2. For this subgroup of 49 patients, if we consider
“abnormal” as the only correct response, the sensitivity by
perfusion imaging alone was 78% compared with 92% with the
addition of gating. This result is not significant (p 5 0.09,
two-tailed). If we included “borderline abnormal” as a correct
response, there was no difference.
As previously noted, this is a consecutive study of clinically
referred patients. It is not designed to accurately indicate test
sensitivity or specificity. The subgroup of 49 patients discussed
in the previous paragraph was the group most likely to have an
abnormal interpretation. If we exclude the patients with a
previous myocardial infarction and use $70% for the angio-
graphic classification of coronary artery disease, then sensitiv-
ity is 91% (29 of 32 patients), including borderline abnormal as
being correct. If we exclude the patients with a previous
myocardial infarction and use $50% for angiographic classifi-
cation of coronary artery disease, then sensitivity is 86% (32 of
37 patients).
Thus, the addition of gated images leads to correctly
interpreting significantly more normal scans and more abnor-
mal scans without equivocation. Test specificity was increased
by the addition of gated images, whereas sensitivity was not
significantly changed.
Discussion
This study, which was undertaken in a sequential group of
heterogeneous patients referred to the Nuclear Cardiology
Laboratory for testing, showed that the addition of gated
SPECT acquisition for the assessment of regional systolic
function reduces the degree of uncertainty in the interpreta-
tion of stress and rest Tc-99m sestamibi SPECT perfusion
studies. The number of “borderline normal” and “borderline
abnormal” interpretations when perfusion images were read
without the gated images were significantly reduced when the
gated tomograms were interpreted simultaneously with perfu-
sion images, yielding better separation of normal from abnor-
mal studies for coronary artery disease detection. It should be
pointed out that when artifacts (e.g., breast attenuation, dia-
phragmatic attenuation) were unequivocally identified on per-
fusion images, those studies were read as normal or borderline
normal. The “borderline abnormal” designation was used only
when the interpreters could not clearly identify that the defect
was truly artifactual or that it was clearly characteristic of a
moderate or severe, reversible or nonreversible defect attrib-
utable to coronary artery disease. As shown in Figures 1 to 3,
the major advantage of gating is to shift the final scan
interpretations to a more normal designation in patients with a
low likelihood of coronary artery disease and to more abnor-
mal defects consistent with known coronary artery disease.
Figure 4. Gated SPECT in 285 patients. Summary of fraction of
studies with unchanged overall readings when perfusion and function
images were interpreted together and the reasons found for changing
or adding to the interpretation of the perfusion images after reviewing
the gated images. WM 5 wall motion.
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In recent years, new Tc-99m-labeled perfusion agents have
emerged for use with SPECT imaging for detecting coronary
artery disease (21–27) and assessing prognosis (28–35). One of
the major advantages of Tc-99m perfusion agents is the high
count density, which permits the acquisition of gated tomo-
grams synchronized to the ECG while sustaining adequate
count density in individual cardiac frames. The ability to
electrocardiographically gate Tc-99m sestamibi tomograms
permits the simultaneous assessment of perfusion and regional
systolic thickening. The method used in the present study was
based on the observation that wall thickening is reflected by an
increase in myocardial count density during systole. Regions
showing Tc-99m sestamibi uptake and preserved systolic thick-
ening are judged to represent viable myocardium. Regions that
demonstrate a nonreversible reduction in Tc-99m sestamibi
uptake on stress to rest images but normal systolic thickening
on stress tomograms would provide evidence to the supposi-
tion that the mild, nonreversible defect in question was due to
an attenuation artifact rather than scar. This is particularly the
case when such a mild reduction in Tc-99m sestamibi uptake
with preserved thickening is seen in the anterior wall in women
or in the high posterobasal region in both men and women.
Regions showing a persistent reduction in Tc-99m sestamibi
uptake with absent systolic thickening would indicate a zone of
irreversible myocardial injury or myocardial hibernation or
stunning. These last two states are more likely to be associated
with a mild to moderate reduction in tracer uptake in associ-
ation with the absence of thickening.
Najm et al. (4) reported that the measurement of fractional
shortening on the anterior Tc-99m sestamibi images derived
from analysis of diastolic and systolic images correlated closely
(r 5 0.89) with echocardiographic fractional shortening.
Tischler et al. (7) reported excellent intraobserver and intraob-
server agreement for global and segmental Tc-99m sestamibi
wall motion analysis. These investigators also showed excellent
agreement with echocardiographic wall motion assessment.
Chua et al. (6) also found that gated SPECT acquisition of
stress-injected Tc-99m sestamibi correlated well with echocar-
diographic assessment of regional function (r 5 0.96).
One significant feature of gated Tc-99m sestamibi SPECT is
the ability to distinguish fixed myocardial defects due to
infarction from fixed defects due to artifact. DePuey and
Rozanski (12) performed gated stress Tc-99m sestamibi imag-
ing in 551 consecutive patients referred for evaluation of
coronary artery disease. In that study, in 96% of the fixed
defects in patients with clinical documentation of infarction,
regional function was abnormal, whereas in 77% of the fixed
defects in patients without previous documented clinical in-
farction, regional function was normal. Because 91% of the
fixed defects with normal systolic function occurred in either
women with anterior fixed defects or men with inferior fixed
defects, they were considered to be most likely due to attenu-
ation artifacts. The data from the present study are consistent
with the data of DePuey and Rozanski (12), in that assessment
of the gated images resulted in a significant reduction in the
number of borderline normal or questionable artifact interpre-
tations. In the present study, a mild reduction in Tc-99m
sestamibi activity associated with normal systolic thickening
was interpreted in the final reading as a normal segment.
More recently, several groups of investigators have shown
that the left ventricular ejection fraction can also be measured
from gated Tc-99m sestamibi SPECT imaging (14–17). Some
of these methods use automatic ejection fraction quantitation,
whereas others require that the endocardial borders be man-
ually traced by an observer. In all these studies, left ventricular
ejection fraction calculated from gated Tc-99m sestamibi
SPECT images correlate well with other techniques, such as
radionuclide angiography and contrast ventriculography.
Thus, both regional and global function can be evaluated on
the gated Tc-99m sestamibi tomograms, allowing for the
simultaneous assessment of perfusion and function. Not only
will this functional assessment enhance the sensitivity and
specificity of gated Tc-99m sestamibi SPECT imaging for the
detection of coronary artery disease, but it should also allow
for the determination of viability in fixed defects and provide
supplementary information for prognosis with measurement of
the global left ventricular ejection fraction.
Study limitations. One of the limitations of the study is
that not all patients underwent coronary angiography. Even
among those who did, we have no absolute standard to
determine the reserve capacity of individual coronary arteries
or the contribution of collateral flow to regions supplied by
arteries with anatomic obstruction. Because we do not know if
an individual segment should or should not have a perfusion
defect, we cannot determine with certainty if the classification
or reclassification of an individual myocardial segment is
correct. We can show that the addition of gated tomograms
resulted in a greater number of “normal” classifications in the
group of patients with a low likelihood of having significant
coronary artery disease and a greater number of “abnormal”
classifications within the group of patients with a high likeli-
hood or with proven coronary artery disease. We therefore
infer that the addition of wall motion information is more
likely to lead us to a correct interpretation than to an incorrect
interpretation.
Another limitation of the study was that no follow-up was
performed to determine whether the patients who had final
interpretations of normal or abnormal studies had different
cardiac event rates. However, another study from our group
did show that patients with a normal Tc-99m sestamibi SPECT
perfusion scan had an excellent 1-year event-free survival rate
(34). It would be expected that a similar low event rate would
be the result in the patients in the present study, who were
finally designated as having a normal or borderline normal
perfusion scan.
Clinical implications. The major clinical implication of this
study is that the addition of gated acquisition for exercise or
pharmacologic stress Tc-99m sestamibi SPECT myocardial
perfusion imaging should result in less uncertainty in interpret-
ing studies that, on review of SPECT perfusion images alone,
might yield interpretations designated as “borderline normal”
or “borderline abnormal.” This is because attenuation artifacts
1691JACC Vol. 30, No. 7 SMANIO ET AL.
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are more easily distinguished from myocardial scar in such
patients.
We are grateful to Jerry Curtis for superb editorial assistance in preparing the
manuscript and to the technical personnel of the nuclear cardiology laboratory
for outstanding support in conducting this study.
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